| USD ($) $ in Millions | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current assets: | |||||||||||||||||
ASSETS | |||||||||||||||||
Cash and cash equivalents | $ 3,368.0 | $ 2,027.4 | $ 2,750.1 | ||||||||||||||
Short-term investments | 2,566.9 | 1,985.9 | 2,473.1 | ||||||||||||||
Accounts receivable, net of allowances of $29.9 and $30.7 as of December 31, 2025, and 2024, respectively | 1,527.3 | 1,225.4 | 1,130.2 | ||||||||||||||
Inventory | 1,840.0 | 1,487.2 | 1,220.6 | ||||||||||||||
Prepaids and other current assets | 477.3 | 385.1 | 314.0 | ||||||||||||||
Prepaids and other assets | - | - | - | ||||||||||||||
Deferred tax assets | 1,018.6 | 1,045.1 | 910.5 | ||||||||||||||
Total current assets | 9,779.5 | 7,111.0 | 7,888.0 | ||||||||||||||
Property, plant, and equipment, net | 5,342.4 | 4,646.6 | 3,537.6 | ||||||||||||||
Long-term investments | 3,099.2 | 4,819.1 | 2,120.0 | ||||||||||||||
Deferred tax assets | - | - | - | ||||||||||||||
Intangible and other assets, net | 848.7 | 773.9 | 636.7 | ||||||||||||||
Intangible and other assets, net | - | - | - | ||||||||||||||
Goodwill | 370.3 | 347.5 | 348.7 | ||||||||||||||
Other assets | - | - | - | ||||||||||||||
Total assets | 20,458.7 | 18,743.2 | 15,441.5 | ||||||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | 255.1 | 193.4 | 188.7 | ||||||||||||||
Accrued compensation and employee benefits | 648.4 | 535.6 | 436.4 | ||||||||||||||
Deferred revenue | 506.7 | 468.8 | 446.1 | ||||||||||||||
Other accrued liabilities | 596.0 | 547.5 | 587.5 | ||||||||||||||
Total current liabilities | 2,006.2 | 1,745.3 | 1,658.7 | ||||||||||||||
Other long-term liabilities | 510.8 | 468.3 | 385.5 | ||||||||||||||
Deferred revenue | - | - | - | ||||||||||||||
Total liabilities | 2,517.0 | 2,213.6 | 2,044.2 | ||||||||||||||
Stockholders’ equity: | |||||||||||||||||
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2025, and 2024 | 0.0 | 0.0 | 0.0 | ||||||||||||||
Common stock, 600.0 shares authorized, $0.001 par value, 355.1 shares and 356.6 shares issued and outstanding as of December 31, 2025, and 2024, respectively | 0.4 | 0.4 | 0.4 | ||||||||||||||
Additional paid-in capital | 10,768.5 | 9,681.3 | 8,576.4 | ||||||||||||||
Retained earnings | 7,011.8 | 6,803.3 | 4,743.0 | ||||||||||||||
Accumulated other comprehensive income (loss) | 43.3 | (51.3) | (12.2) | ||||||||||||||
Total Intuitive Surgical, Inc. stockholders’ equity | 17,824.0 | 16,433.7 | 13,307.6 | ||||||||||||||
Noncontrolling interest in joint venture | 117.7 | 95.9 | 89.7 | ||||||||||||||
Total stockholders’ equity | 17,941.7 | 16,529.6 | 13,397.3 | ||||||||||||||
Total liabilities and stockholders’ equity | $ 20,458.7 | $ 18,743.2 | $ 15,441.5 |